Beta
Trial Radar KI
Die klinische Studie NCT06912178 für Chronic Atrophic Gastritis (CAG) ist noch nicht rekrutierend. In der Kartenansicht des Klinische Studien Radar und den KI-Entdeckungstools finden Sie alle Details. Oder stellen Sie hier Ihre Fragen.
Eine Studie entspricht den Filterkriterien
Kartenansicht

Association of Sleep Quality With Pathologic Staging, Acupuncture Treatment in Patients With Chronic Atrophic Gastritis: a Cross-sectional Study 120 Beobachtend

Noch nicht rekrutierend
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT06912178 ist eine beobachtungsstudie zur Untersuchung von Chronic Atrophic Gastritis (CAG) und hat den Status noch nicht rekrutierend. Der Start ist für 30. März 2025 geplant, bis 120 Teilnehmer aufgenommen werden. Durchgeführt von Yi Liang wird der Abschluss für 30. März 2026 erwartet. Die Daten von ClinicalTrials.gov wurden zuletzt am 4. April 2025 aktualisiert.
Kurzbeschreibung
In order to inform clinical treatment decisions and maximize treatment outcomes, this observational study set out to examine the relationship between pathological severity and sleep quality in patients with CAG. The idea that "if the stomach is not in harmony, you will be restless" is supported by this evidence from traditional Chinese medicine. Assessing patients' knowledge and acceptance of acupuncture therapy, det...Mehr anzeigen
Ausführliche Beschreibung
This is a single-center, cross-sectional study
Offizieller Titel

Association of Sleep Quality With Pathologic Staging, Acupuncture Treatment in Patients With Chronic Atrophic Gastritis: a Cross-sectional Study

Erkrankungen
Chronic Atrophic Gastritis (CAG)
Weitere Studien-IDs
  • 20250303032132260
NCT-Nummer
Studienbeginn (tatsächlich)
2025-03-30
Zuletzt aktualisiert
2025-04-04
Studienende (vorauss.)
2026-03-30
Geplante Rekrutierung
120
Studientyp
Beobachtungsstudie
Status
Noch nicht rekrutierend
Stichwörter
chronic atrophic gastritis; sleep quality; OLGA; OLGIM; pathologic; acupuncture; cross-sectional
Studienarme/Interventionen
Teilnehmergruppe/StudienarmIntervention/Behandlung
Nicht zutreffend
Akupunktur
Whether or not a patient has been treated with acupuncture will be one of the exposure factors of interest in the study
Hauptergebnismessungen
ErgebnismessungBeschreibung der MessungZeitrahmen
The correlation coefficient between various pathological stages of Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia (OLGIM) and sleep quality in patients with chronic atrophic gastritis (CAG) is the main o
General condition (age, gender, height, weight, etc.), occupation, personal and family history, Helicobacter pylori infection history, acupuncture treatment, Pittsburgh sleep quality index, serum pepsinogen index, gastroscopy results, and clinical data (OLGA and OLGIM for gastric mucosal histopathology) were among the information that the researchers gathered. The association between the histological stages of OLGA and OLGIM in stomach mucosal histopathology and the sleep quality index in CAG patients was then examined by the researchers.
Gastroscopy and pathology reports within one year and sleep quality assessment within one week of participant enrollment
Nebenergebnismessungen
ErgebnismessungBeschreibung der MessungZeitrahmen
Acupuncture treatment response and sleep quality relationships, as well as other pertinent risk factors, were secondary outcomes
The clinical research program of acupuncture and moxibustion with CAG with sleep disturbances was further adjusted to evaluate the relationship between acupuncture treatment and sleep quality in CAG patients. The researchers looked into how CAG patients were treated overall, including whether they had previously undergone acupuncture treatment, their preferences for different acupuncture treatments, and their willingness and acceptance of acupuncture treatment. Additionally, the quality of the CAG patients' sleep throughout the previous month was examined.
Patient's treatment to date after diagnosis of chronic atrophic gastritis, and whether participant has received acupuncture in the last 3 months
Teilnahme-Assistent
Eignungskriterien

Zugelassene Altersgruppen
Erwachsene, Ältere Erwachsene
Mindestalter
18 Years
Zugelassene Geschlechter
Alle
  1. Have been diagnosed with chronic atrophic gastritis;
  2. Be between the ages of 18 and 75, with no restrictions on gender;
  3. Read the informed consent form, sign it, and consent to participate in this study.

  1. autoimmune gastritis (chronic atrophic gastritis type A);
  2. patients with gastroesophageal reflux disease (GERD) as determined by endoscopy or other examinations, or patients with high-grade intraepithelial neoplasia pathologically as determined by upper gastrointestinal endoscopy and gastric mucosal biopsy;
  3. patients with confirmed or unexcluded malignant tumors, particularly esophageal and gastric cancer;patients with other upper gastrointestinal pathologies, such as Barrett's esophagus or peptic ulcer;
  4. additional physical, mental, psychological, or pathological conditions that may impact sleep scores, such as the use of medications for insomnia, night shifts, jet lag, major events, severe neurosis, menopausal syndrome, uncontrolled hyperthyroidism, severe diabetic peripheral neuropathy, within a month after surgical trauma, etc.
  5. People who use medicines that can make you sleepy at the same time and stop using them for less than a month;
  6. People who can't finish the questionnaire because they're unconscious, can't talk regularly, or have other issues; people who don't have enough information.
Yi Liang logoYi Liang
Zhejiang Provincial Department of Science and Technology logoZhejiang Provincial Department of Science and Technology
Verantwortliche Partei
Yi Liang, Prüfsponsor, Research Fellow, The Third Affiliated hospital of Zhejiang Chinese Medical University
Zentrale Studienkontakte
Kontakt: Yi Liang, Doctor, +86 571 86633328, [email protected]
1 Studienstandorte in 1 Ländern
the Ethics Board of Te Thnird Affiliated Hospital of Zhejjiang Chinese Medicinal University, Hangzhou, China